Low-power AMI (active medical implants) firms fight to retain waveband
This article was originally published in Clinica
Executive Summary
Manufacturers of ultra-low power active medical implants (ULP-AMIs) are having to fight to keep the frequency band at which their instruments have traditionally worked. National frequency regulators in Europe are challenging implant manufacturers' rights to use 9-315 kHz, arguing that this waveband could be subject to interference that could harm patients and others users of the frequency.